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Abstract 
We have studied the PKC isoforms present in HT-29 M6 colon cancer cells, the differentiation of which to mucus-secreting cells is blocked by 
TPA. In addition to a major 72 kDa band, a 77 kDa PKC isoform was recognized by two different antibodies raised against a C-terminus-specific 
peptide for the TPA-insensitive isoform, PKCC. By different criteria (association to the membrane, down-regulation, PKC activity in immunoprecip- 
itates) we conclude that, contrary to the 72 kDa band, the 77 kDa band corresponds to a Ca’+- and TPA-sensitive PKC. These results suggest that 
antipeptide antibodies directed against the C-terminus of PKC[ react in human cells with a member of the conventional PKC subfamily besides PKCC. 
Therefore, the data indicating that PKCC is sensitive to different agents in various cell lines should be carefully re-evaluated. 
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1. Introduction 
Protein kinase C (PKC) plays a crucial role in the 
signal transduction mechanisms activated by growth fac- 
tors, hormones and neurotransmitters [1,2]. Several 
members of this extended family have been described so 
far; these protein kinases have been classified in to three 
different subfamilies [1,2]. The conventional PKC sub- 
family (cPKC) comprises four members a, /?I, PII and y; 
these isoforms require Ca2’, phospholipid and dia- 
cylglycerol or phorbol ester for activation. The novel 
PKC subfamily (nPKC), composed of isoforms 6, E, q 
and 19, lacks the Ca2’-binding domain and the activity of 
its members is independent of Ca2’ [l-3]. Recently, two 
other PKC isoforms, c and z, have been gathered into a 
new subfamily, atypical PKCs (aPKC), in accordance 
with their insensitivity to diacylglycerol, the natural acti- 
vator of the other PKCs [1,4]. 
Antibodies raised against peptides specific for the dif- 
ferent isoforms of PKC have been used as a powerful 
tool to examine the presence of the members of the PKC 
family in different cells and tissues. Among them, the 
presence of aPKCc has received a growing interest since 
this PKC isoform has been shown to be involved in 
mitogenesis in several systems [5,6]. C-Terminus-directed 
antipeptide antibodies have been widely used to study 
*Corresponding author. 
the distribution of this PKC by many groups in human 
[779] and other species [5,10-171. In this work we demon- 
strate that these antipeptide antibodies are not specific 
and also react with a Ca2’- and TPA-sensitive PKC in 
human intestinal epithelial cells. 
2. Materials and methods 
2.1. Materials 
Phosphatidylserine (PS), I-oleoyl-2-acetyl-glycerol, histone III& my- 
elin basic protein (MBP), 12-O-tetradecanoylphorbol-13-acetate (TPA) 
and phenyl-methyl sulphonyl fluoride (PMSF) were supplied by Sigma 
(St. Louis, MO). The PKC inhibitor GFl09203X was kindly provided 
by Dr. J. Moscat (CSIC, Madrid). Leupeptin was from Boehringer 
(Mannheim, Germany). Protein A-agarose was from ICN Biochemicals 
(Cleveland, OH). DEAE-Sephacel was from Pharmacia (Uppsala, Swe- 
den). [Y-~~P]ATP was purchased from New England Nuclear. Pre- 
stained SDS-PAGE molecular weight (Mw) markers were from Bio- 
Rad. All the other chemicals were commercial products of the highest 
grade available. 
2.2. Antibodies 
The following antibodies were used in our study. Anti-cPKC, anti- 
peptide antibody from Gibco/BRL (Gaithersburg, MD), raised against 
peptide ILKKDVIVQDDDVD, common to cPKCcl (amino acid resi- 
dues 369-382) cPKC/I (372-385) and cPKCy (381-394). Anti-cPKCa, 
monoclonal antibody (mAb) MC5 (Amersham), mapped to residues 
312-323 (kindly provided by Dr. D. Colomer, Hospital Clinic, Barce- 
lona). Anti-nPKC&, antipeptide antibody from Gibco, raised against 
peptide DGFSYFGEDLMP (amino acid residues 726737). Anti- 
aPKCc, antipeptide antibody from Gibco, raised against peptide 
GFEYINPLLLSAEESV (amino acid residues 577-592). A polyclonal 
antibody was prepared in our laboratory by immunizing rabbits with 
this same aPKCc-specific peptide (synthetized by Dr. D. Andreu, De- 
partament de Quimica Organica, Universitat de Barcelona) coupled to 
keyhole limpet hemocyanine (KLH) by m-maleimido benzoic acid- 
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hydroxysuccinimide ester (MBS). Serum was collected according to 
standard protocols and used at a l:l,OOO dilution, without further 
purification. 
2.3. Cell culture 
The HT-29 M6 cell line, originally described and characterized with 
the name HT-29 (10e6 methotrexate) 1181 was provided bv Dr. Alain 
Zweibaum (INSERM, Villejuif, France)._ Cells-were cultured in Dul- 
becco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum (Gibco) as previously described [19]. 
2.4. Preparation of cytosol and membrane cell fractions 
Cells were washed twice in buffer A (25 mM Tris HCl, pH 7.6, 1 mM 
EGTA, 10 mM NaCl) and homogenized on ice in a Douncer in this 
buffer containing 1 mM PMSF and 25 pg/ml leupeptin. The homoge- 
nate was centrifugated at 15,000 x g for 30 min at 4°C; the supernatant 
constituted the soluble cytosolic fraction, The pellet was resuspended 
in buffer A-Triton (buffer A plus PMSF and leupeptin and made 1% 
in Triton X-100) by ten strokes in a Douncer homogenizer and allowed 
to stand on ice for 30 min. After centrifugation under the same condi- 
tions as before, the supernatant constituted the detergent-extracted, 
membrane fraction. Occasionally, total extracts were prepared directly 
in buffer A plus Triton. In the cases mentioned, these fractions (total 
homogenate, cytosol or membrane) were purified by chromatography 
on DEAE-Sephacel: fractions were applied to a DEAE-Sephacel col- 
umn pre-equilibrated in buffer A and PKCs were eluted in this same 
buffer made 150 mM in NaCl. 
To separate the 77 and 72 kDa bands an extract was prepared under 
the following conditions. Cells were washed twice with buffer B (25 mM 
Tris-HCl, pH 7.6, 10 mM NaCl, 3 mM CaCl,) and homogenized in 25 
ml of buffer B containing 1 mM PMSF and 25 ,@ml leupeptin by 50 
strokes in a Douncer. After 30 min on ice, the homogenate was centri- 
fugated for 30 min at 15,000 x g. The pellet was washed once with the 
same buffer and spun under the same conditions. After this second 
centrifugation, the pellet was resuspended in 10 ml of buffer C (25 mM 
Tris-HCl, pH 7.6, 10 mM NaCl, 4 mM EGTA) plus PMSF and le- 
upeptin by ten strokes in a Douncer, and allowed to stand on ice for 
30 min. After centrifugation (same conditions as before), the superna- 
tant constituted the EGTA wash fraction. This fraction was usually 
purified by chromatography on DEAE-Sephacel as mentioned above. 
2.5. PKC activity 
PKC activity was assayed under the conditions described [20] using 
lvsine-rich histone (histone III-S) or MBP (0.5 mg/ml in both cases) as . _ 
substrates and immunoprecipitates as the source of the enzyme. 6ne 
unit of activity was defined as one pmol of phosphate incorporated into 
the substrate per minute. Autophosphorylation reactions were carried 
out under the same protein kinase conditions except that exogenous 
substrates were omitted and ATP was used at 2 ,uM with a specific 
activity of 5 x lo4 cpm/pmol. Phosphorylation of the 77 kDa band was 
detected after SDS-PAGE in 10% gels and autoradiography. 
2.6. Other methods 
Western blot analysis was performed exactly as described [19]. Pro- 
tein concentration was determined by the Bradford method (Bio-Rad) 
with bovine serum albumin (BSA) as standard. 
3. Results 
The phorbol ester TPA has been shown to produce 
remarkable morphological changes in HT-29 M6 cells, 
inhibiting their differentiation to a mucus-secretive phe- 
notype [19] and altering cell-cell contacts [21]. As a first 
step to characterize the mechanism by which TPA exerts 
these effects, we have studied the presence of the different 
PKCs in HT-29 M6 cells, using antibodies raised against 
synthetic isoform-specific peptides. These antibodies, 
purchased from Gibco, have been used previously in 
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Fig. 1. Western blot analysis of HT-29 M6 PKC isoforms. Cells were 
homogenized in buffer A plus 1% Triton X-100, 1 mM PMSF, 25,&g/ml 
leupeptin as described in section 2. (A) Total cell homogenates (300 pg 
of protein) (HOM) or PKCs purified by DEAE-Sephacel chromatogra- 
phy (13 pg) (DE) were analyzed by SDS-PAGE in 10% polyacrylamide 
gels and immunoblotted with antibodies specific for cPKCs, aPKC[ 
and nPKC.s as described. The bars indicate the position of the 116, 80, 
49 and 32 kDa molecular weight markers, (B) DEAE-Sephacel-purified 
PKC fraction (DE-150) (15 pug) was subjected to SDS-PAGE on 10% 
gels, over-running the gels until the pre-stained 49 kDa molecular 
weight marker was 1 cm from the bottom. Proteins were transfered and 
analyzed with the antibodies against the different isoforms of PKC as 
mentioned. Only the 116, 80 and 49 kDa molecular weight markers are 
shown. 
similar studies by several groups in different cellular sys- 
tems [7-171. The analysis by immunoblot of total cell 
extracts showed that HT-29 M6 cells contain abundant 
nPKC& and aPKCc, and low levels of cPKC (Fig. 1A). 
The antipeptide antibody used in this first assay did not 
distinguish between the different isoforms of this sub- 
family; however, cPKCol was detected when blotting 
with the specific mAb MC5 (not shown). The im- 
munoblot was repeated with PKCs partially purified by 
chromatography on DEAE-Sephacel. Results obtained 
with this fraction were similar to those obtained with 
extracts concerning cPKC or nPKC&, however, the pres- 
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ence of a band of slightly higher molecular weight than 
the major PKCC form was clearly observed in this frac- 
tion (Fig. 1A). This band was faint in total homogenates 
but was enriched during this purification step. In order 
to better separate the two bands, SDS-PAGE was per- 
formed over-running the 10% polyacrylamide gels. The 
two bands observed with the anti-aPKC[ antibody were 
clearly separated (Fig. 1B); their estimated molecular 
weights corresponded to 77 and 72 kDa. 
The response of the different PKC isoforms to TPA 
addition was examined. cPKC and PKCE were rapidly 
degraded after TPA stimulation of HT-29 M6 cells (not 
shown). The two bands detected with the aPKC[ antise- 
rum responded differently to TPA; while the 72 kDa 
form was not affected, the 77 kDa form was almost 
completely down-regulated after 24 h of incubation with 
this phorbol ester (Fig. 2A). The effect of TPA on the 
cellular distribution of these forms was also studied. 
When cell extracts were prepared in the presence of 
EGTA, both forms were mainly detected in the cytosol 
fraction (Fig. 2B). A similar distribution of aPKCc has 
been observed in other systems [11,14,22]. TPA induced 
a rapid and complete translocation of the 77 kDa form, 
but not the 72 kDa form, from the soluble to the deter- 
gent-solubilized fraction, presumably membranes (Fig. 
2B). The same results were obtained in three independent 
experiments. The translocation of the 77 kDa was com- 
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Fig. 2. The 77 kDa PKC is sensitive to TPA. HT-29 M6 cells were 
grown in complete DME medium supplemented with 10% FBS. Cells 
were incubated with TPA (400 nM) or the vehicle alone (DMSO) for 
24 h (panel A) or 1 h (panel B). Cells were harvested and total cellular 
homogenates (T) (panel A) or cytosolic (C) and membrane (M) frac- 
tions (panel B) were prepared as described in section 2. After purifica- 
tion by DEAE-Sephacel chromatography, PKC forms were analyzed 
as mentioned in Fig. 1 with the antibody raised against the C-terminus 
of PKCl. The bars indicate the position of the 205, 116, 80, 49 and 32 
kDa pre-stained molecular weight markers. This figure shows the re- 
sults of a representative experiment of a total of five performed. 
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Fig. 3. The 77 kDa PKC form associates with the membrane in the 
presence of Ca”. Cells were homogenized either in the presence of Ca*’ 
(buffer B plus 1 mM PMSF and 25 pg/ ml leupeptin) or in the presence 
of EGTA (buffer A plus these protease inhibitors) with a Douncer and 
centrifuged as described; the supernatant constituted the cytosolic frac- 
tion (C). The pellet was extracted with buffers A or B (plus protease 
inhibitors) supplemented with 1% Triton X-100; after centrifugation the 
supernatant constituted the membrane fraction (M). After chromatog- 
raphy in DEAE-Sephacel, the presence of the 77 kDa band was ana- 
lyzed as mentioned. 
plete in 15 min; no changes in the total cellular levels of 
this form were detected within 6 h of TPA addition (data 
not shown). 
The characteristics of this TPA-sensitive PKCC form 
were studied in greater detail. First, its association with 
the membrane fraction was examined. As already men- 
tioned, when cell extracts were prepared in the presence 
of EGTA, both the 72 and 77 kDa PKC forms were 
detected mainly in the cytosol fraction. However, when 
extracts were obtained in the presence of Ca2’ (3 mM), 
the 77 form kDa was predominantly associated to the 
Triton-solubilized membrane fraction (Fig. 3). This 
stronger association to the membrane in the presence of 
Ca” suggested that the antibody raised against the C- 
terminus of aPKCc was recognizing a Ca”-dependent 
PKC isoform as well. 
To further study the characteristics of the 77 kDa 
enzyme, PKC kinase activity was determined in im- 
munoprecipitates obtained with the antipeptide antibody 
from fractions devoided of 72 kDa aPKCc. This fraction 
(EGTA wash) was prepared by taking advantage of the 
different associations to the membrane of both PKCs 
(see above). After chromatography in DEAE-Sephacel, 
the 77 kDa PKC form was immunoprecipitated with the 
C-terminus aPKC< antipeptide antibody. PKC activity 
was observed when MBP was used as the substrate (Fig. 
4A); this PKC phosphorylated histone Hl with much 
lower affinity (not shown). Maximal activity was ob- 
served in the presence of PS, TPA and Ca2’ (Fig. 4A); 
this ion stimulated the PKC activity in these conditions 
(plus PS and TPA) from 40 to 100% in different experi- 
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Fig. 4. Autophosphorylation and MBP kinase activity in 77 kDa PKC 
immunoprecipitates. 200 ,~l (150 pg) of EGTA wash fraction, purified 
by DEAE-Sephacel, was incubated with anti-PKCC antibody (1:200) 
for 12 h at 4°C in the presence of leupeptin (25 ,@ml). Immunocom- 
plexes were recovered with protein A-Sepharose, washed and assayed 
for the MBP kinase (A) or autophosphorylation (B) assays under the 
conditions indicated. Essentially identical results were obtained in three 
independent experiments. Panel A, lanes: 1, EGTA (1 mM); 2, EGTA 
and PS (80 &ml); 3, PS, EGTA and TPA (400 nM); 4, PS, TPA and 
Ca*’ (10 ,uM); and 5, PS, TPA, Ca” and GF (1 PM). Panel B, lanes: 
1, EGTA; 2, EGTA and PS; 3, EGTA, PS and TPA; 4, PS, TPA and 
Ca’+ (10 PM); 5, PS, TPA and Ca” (50,~M); and 6, PS, TPA, Ca’+ (50 
,uM) and GF. To determine the free Ca’+ in the assay, an apparent 
association constant of 2 x lo6 M-’ for the Ca”-EGTA complex was 
used. 
ments. DAGs like 1-oleoyl-2-acetyl-glycerol stimulated 
the activity to a similar degree as TPA (not shown). The 
PKC-specific inhibitor GF [23] completely blocked this 
activity at a concentration of 0.5 ,uM (Fig. 4A). Similar 
results were obtained when the autophosphorylation of 
77 kDa band was examined in immunoprecipitates. Au- 
tophosphorylation was even more dependent on the 
presence of Ca” than the MBP kinase activity and was 
also blocked by the inhibitor GF (Fig. 4B). 
These results suggest that the PKCC antipeptide anti- 
body was reacting with a cPKC as well. In order to check 
that these results were not an artifact of a particular 
batch of the antibody, the Western blot analysis was 
repeated with two other different batches. No differences 
were observed; a 77 kDa band was always present in 
HT-29 M6 cells extracts. Moreover, an antibody directed 
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against the C-terminus of PKCC was prepared in our lab; 
the peptide corresponding to residues 577-592 from rat 
brain PKCC was synthetized, coupled to KLH using 
MBS, and used to immunize rabbits. The antiserum ob- 
tained showed identical reactivity to Gibco’s; in addition 
to a predominant 72 kDa band, it recognized and im- 
munoprecipitated a 77 kDa band with Ca2+- and TPA- 
dependent PKC activity (data not shown). 
4. Discussion 
In this article we show that antipeptide antibodies, 
prepared against a peptide corresponding to the C-termi- 
nus of aPKCc, recognize, in addition to a 72 kDa band 
(presumingly aPKC0, another band of 77 kDa in HT-29 
M6 cells. This band corresponds to a cPKC since it is 
translocated and down-regulated after addition of TPA 
to the cells and, when immunoprecipitated by this anti- 
body, presents a MBP kinase activity dependent on Ca*‘, 
phospholipid and TPA. 
When the sequences of the different PKCs are com- 
pared, the aPKCc C-terminus peptide (amino acids 577- 
592) was only observed in this isoform; no analogies with 
this peptide were found in other PKCs. For this reason 
this peptide was chosen to raise PKC[-specific antibod- 
ies by Gibco and several authors, and used by many 
groups to determine the presence of this isoform in 
human [7-91 and other species [lo-171. Very recently, it 
has been reported that this antipeptide antibody also 
recognizes a newly described PKC, aPKCz [4]. This 
isoform is clearly different from the 77 kDa cPKC since 
it has a lower molecular weight and does not respond to 
TPA or Ca2’ [4]. 
Our results suggest that the use of these antibodies as 
the only tool to examine the presence of PKCC in differ- 
ent cell systems could lead to erroneous conclusions. 
This finding is especially relevant because there is not a 
simple way to identify PKCC among the different bands 
that show up on an immunoblot since (i) this PKC 
isoform does not respond to TPA by translocation or 
down-regulation like the rest of the PKCs, and (ii) the 
molecular weight of PKCC has been shown to be sub- 
stantially different in various cell systems, oscillating in 
a range from 68 to 80 kDa [3,7,14,16,24]. Additional 
analysis with other PKCC-specific antibodies would be 
required in order to verify the presence of this isoform 
in different systems. 
The identity of the cPKC isoform recognized by the 
antibody is still a matter of study. Previous experiments 
from our laboratory suggest that the 77 kDa band is 
different from the 01 or j? cPKCs since its behaviour in 
columns of hydroxyapatite is not the same. A a more 
definitive answer to this question would require the isola- 
tion and sequencing of cDNAs coding for this PKC 
isoform. 
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